CN105267711A - Pharmaceutical preparation for treating vertigo - Google Patents

Pharmaceutical preparation for treating vertigo Download PDF

Info

Publication number
CN105267711A
CN105267711A CN201510848213.4A CN201510848213A CN105267711A CN 105267711 A CN105267711 A CN 105267711A CN 201510848213 A CN201510848213 A CN 201510848213A CN 105267711 A CN105267711 A CN 105267711A
Authority
CN
China
Prior art keywords
parts
radix
vertigo
pharmaceutical preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510848213.4A
Other languages
Chinese (zh)
Inventor
王菊明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Fengling Pharmaceutical Co Ltd
Original Assignee
Suzhou Fengling Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Fengling Pharmaceutical Co Ltd filed Critical Suzhou Fengling Pharmaceutical Co Ltd
Priority to CN201510848213.4A priority Critical patent/CN105267711A/en
Publication of CN105267711A publication Critical patent/CN105267711A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicine preparations and particularly provides a pharmaceutical preparation for treating vertigo. The pharmaceutical preparation is prepared from the following raw materials: 25 parts of hard melandrium herb, 20 parts of Acanthus ilicifolius, 22 parts of Viburnum nervosum, 28 parts of sharpleaf cayratia root, 18 parts of celastrus flagellaris, 26 parts of maidenhair spleenwort, 15 parts of poria with hostwood, 25 parts of cicada slough, 28 parts of corydalis tuber, 15 parts of glossy privet fruit, 15 parts of cassia twig, 20 parts of keel, 25 parts of selfheal, 20 parts of dogwood, 25 parts of astragalus, 20 parts of gastrodia elata, 15 parts of uncaria and 5 parts of liquorice. The pharmaceutical preparation disclosed by the invention can be used for treating vertigo.

Description

A kind of pharmaceutical preparation being used for the treatment of vertigo
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to a kind of pharmaceutical preparation being used for the treatment of vertigo and its preparation method and application.
Background technology
Dizzyly refer to blurring of vision or dark and dim eyesight; Swoon and refer to self-induction health or external scene rotary oscillation, astasia.The two often occurs simultaneously, therefore is referred to as dizzy.Slight dizzy person closes order and namely stops.The dizzy person of severe as boat by bus, or with nausea and vomiting, nervously to perspire, even limbs deflection is for the symptom such as falling.For this reason, be bursting to and develop the needs that more medicines for the treatment of vertigo safely and effectively meet clinical treatment.
Summary of the invention
In order to solve the problem, the object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of vertigo disease.In order to reach this object, adopt following technical scheme:
Technical scheme: a kind of pharmaceutical preparation being used for the treatment of vertigo, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Herba melandrii firmi 25 parts, Radix seu Caulis Acanthi Ilicifolii 20 parts, Radix Viburni Cordifolii 22 parts, Radix Cayratiae trifoliae 28 parts, sting luxuriant Celastrus orbiculatus Thunb. 18 parts, Herba asplenii trichomanis 26 parts, Poria cum Radix Pini 15 parts, Periostracum Cicadae 25 parts, Rhizoma Corydalis 28 parts, Fructus Ligustri Lucidi 15 parts, Ramulus Cinnamomi 15 parts, Os Draconis 20 parts, Spica Prunellae 25 parts, Fructus Corni 20 parts, the Radix Astragali 25 parts, 20 parts, Rhizoma Gastrodiae, Ramulus Uncariae Cum Uncis 15 parts, 5 parts, Radix Glycyrrhizae.
The described pharmaceutical preparation being used for the treatment of vertigo, dosage form is pharmaceutically acceptable granule, tablet, capsule.
The described pharmaceutical preparation being used for the treatment of vertigo, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
The described application of pharmaceutical preparation in preparation treatment vertigo medicine being used for the treatment of vertigo.
Herba melandrii firmi is the herb of the sturdy Herba Melandrii Aprici of pinkwort.Latin name: SilenefirmaSieb.EtZucc., gathers during 8 ~ JIUYUE seed maturity, dries.Heat-clearing and toxic substances removing; Diuresis; Regulating menstruation.Cure mainly laryngopharynx swelling and pain; (ear booth) ear comes to a head; Dysuria.
Radix seu Caulis Acanthi Ilicifolii is root and the stem of acanthaceous plant Radix seu Caulis Acanthi Ilicifolii, and the whole year can adopt, and cleans section, dries.Lightly seasoned, cold in nature.Control mumps, scrofula.
Radix Viburni Cordifolii is the root of caprifoliaceae plant Xin Ye Caulis Viburni Dilatati.Dispelling the wind and dampness pathogens is numb, bones and muscles pain, falls the damage stasis of blood and coagulates, waist side of body flatulence.
Radix Cayratiae trifoliae is the root of vitaceae Caulis et Folium cayratiae trifoliae, heat-clearing and toxic substances removing.Control lung abscess.
Sting the fruit that luxuriant Celastrus orbiculatus Thunb. is Celastraceae plant Radix Seu Caulis Celastri Flagellaris CelastrusflagellarisRupr., wind-damp dispelling, promoting blood circulation and stopping pain.For rheumatic arthritis, traumatic injury.
Herba asplenii trichomanis is fern Aspleniaceae spleen wort Asplenium trchomanes L. AspleniumtrichomanesL., with all herbal medicine.The four seasons can adopt, and clean, using fresh herb or dry.Heat-clearing and toxic substances removing, regulating menstruation, hemostasis, convergence leukorrhagia stopping.For infantile hyperpyrexia, leucorrhea, menoxenia; Burn and scald is controlled in external, traumatic hemorrhage, furuncle swelling toxin, venom.All the other Chinese medicines are pharmacopeia kind.
Beneficial effect: the traditional Chinese medical science thinks that vertigo can by wind, expectorant, void causes, therefore have " calm do not do dizzy ", " dizziness must be caused by phlegm ", the saying of " dizziness must be due to deficiency ", Herba melandrii firmi of the present invention, Radix seu Caulis Acanthi Ilicifolii, Radix Viburni Cordifolii, Radix Cayratiae trifoliae, sting luxuriant Celastrus orbiculatus Thunb., Herba asplenii trichomanis, Poria cum Radix Pini, Periostracum Cicadae, Rhizoma Corydalis suppressing the hyperactive liver and subsiding YANG, benefiting QI and nourishing blood is monarch drug, Fructus Ligustri Lucidi, Ramulus Cinnamomi, Os Draconis, Spica Prunellae, Fructus Corni, the Radix Astragali, Rhizoma Gastrodiae, Ramulus Uncariae Cum Uncis liver and kidney tonifying, drying dampness to eliminate phlegm is ministerial drug, Radix Glycyrrhizae is adjuvant, the mutual compatibility of full side, suppressing the hyperactive liver and subsiding YANG, benefiting QI and nourishing blood, treatment vertigo successful.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, the preparation of granule embodiment: get Herba melandrii firmi 25g, Radix seu Caulis Acanthi Ilicifolii 20g, Radix Viburni Cordifolii 22g, Radix Cayratiae trifoliae 28g, sting luxuriant Celastrus orbiculatus Thunb. 18g, Herba asplenii trichomanis 26g, Poria cum Radix Pini 15g, Periostracum Cicadae 25g, Rhizoma Corydalis 28g, Fructus Ligustri Lucidi 15g, Ramulus Cinnamomi 15g, Os Draconis 20g, Spica Prunellae 25g, Fructus Corni 20g, Radix Astragali 25g, Rhizoma Gastrodiae 20g, Ramulus Uncariae Cum Uncis 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, and atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add starch 50g, granulate, make granule.
2, the preparation of Tablets Example: get Herba melandrii firmi 25g, Radix seu Caulis Acanthi Ilicifolii 20g, Radix Viburni Cordifolii 22g, Radix Cayratiae trifoliae 28g, sting luxuriant Celastrus orbiculatus Thunb. 18g, Herba asplenii trichomanis 26g, Poria cum Radix Pini 15g, Periostracum Cicadae 25g, Rhizoma Corydalis 28g, Fructus Ligustri Lucidi 15g, Ramulus Cinnamomi 15g, Os Draconis 20g, Spica Prunellae 25g, Fructus Corni 20g, Radix Astragali 25g, Rhizoma Gastrodiae 20g, Ramulus Uncariae Cum Uncis 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds dextrin 50g, granulates, tabletting, makes tablet.
3, the preparation of capsule embodiment: get Herba melandrii firmi 25g, Radix seu Caulis Acanthi Ilicifolii 20g, Radix Viburni Cordifolii 22g, Radix Cayratiae trifoliae 28g, sting luxuriant Celastrus orbiculatus Thunb. 18g, Herba asplenii trichomanis 26g, Poria cum Radix Pini 15g, Periostracum Cicadae 25g, Rhizoma Corydalis 28g, Fructus Ligustri Lucidi 15g, Ramulus Cinnamomi 15g, Os Draconis 20g, Spica Prunellae 25g, Fructus Corni 20g, Radix Astragali 25g, Rhizoma Gastrodiae 20g, Ramulus Uncariae Cum Uncis 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds starch 50g, granulates, fill, makes capsule.
4, traditional Chinese medicine composition for treating vertigo of the present invention clinical research
4.1 general data: this Chinese medicine composition is applied to clinical observation vertigo case 70 example, 46 ~ 65 years old age.The shortest person of the course of disease 3 months, most elder reaches 4 years, average 2.4 years.
4.2 diagnostic criterias: with reference to " dizzy " (at the beginning of foxtail millet show, Huang Ruxun edits, publishing house of The Fourth Military Medical University, the second edition, 2008) diagnostic point: (1) is dizzy looks thing or self sense of rotation, innervation of shaking for ictal, unstable sense, many excuses position or (with) position variation and bringing out.(2) while of dizzy or with the symptom of the transient ischemias such as other brain stems, as eye disease (amaurosis, light, metamorphopsia, diplopia etc.), internal ear pain, numb limbs and tense tendons or unable, damping off, faintness etc.(3) there is slight Detection of brain stem damage sign, as cornea and (or) pharyngeal hyporeflexia or disappearance, regulate and (or) converge like the spokes of a wheel at the hub obstacle, the pathologic reflex etc. of nystagmus that is spontaneous or that bring out after turning neck compressing side vertebral artery and the positive.(4) measuring blood pressure, Lactoferrin of having a blood test, red blood cell count(RBC) and electrocardiogram, electric audiometry, brainstem evoked potential, cervical X-ray are taken the photograph sheet, transcranial Doppler sonography etc. and are helped and clarify a diagnosis.Have ready conditions and do CT or MRI inspection.(5) except the patients with vertigo that tumor, cerebral trauma, hematopathy, cerebral infarction, cerebral hemorrhage etc. cause.
4.3 test methods: prepare clinical sample by above-mentioned process for producing granula, specification is 10 grams every bag, within five days, is a course for the treatment of, one day three bags, take point early, middle and late three half an hour ante cibum.Period in a medicine is avoided eating anything raw or cold, pungent, stimulate and rotten thing.Blank group oral placebo granule five days is a course for the treatment of, one day three bags, point early, middle and late three half an hour ante cibum take.
4.4 criterions of therapeutical effect: recovery from illness: clinical symptoms all disappears, and test chamber inspection is normal.Take a turn for the better: clinical symptom relief, the state of an illness is controlled, lab testing improvement or normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
4.5 therapeutic effect: in table 1.
Table 1 liang group comparitive study
Group n Recovery from illness Take a turn for the better Invalid Total effective rate (%)
Treatment group 35 8 25 2 94.3
Blank group 35 1 2 32 8.6
Visible the present invention has good therapeutic effect to vertigo, and toxic and side effects does not occur treatments period.

Claims (4)

1. one kind is used for the treatment of the pharmaceutical preparation of vertigo, it is characterized in that, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Herba melandrii firmi 25 parts, Radix seu Caulis Acanthi Ilicifolii 20 parts, Radix Viburni Cordifolii 22 parts, Radix Cayratiae trifoliae 28 parts, sting luxuriant Celastrus orbiculatus Thunb. 18 parts, Herba asplenii trichomanis 26 parts, Poria cum Radix Pini 15 parts, Periostracum Cicadae 25 parts, Rhizoma Corydalis 28 parts, Fructus Ligustri Lucidi 15 parts, Ramulus Cinnamomi 15 parts, Os Draconis 20 parts, Spica Prunellae 25 parts, Fructus Corni 20 parts, the Radix Astragali 25 parts, 20 parts, Rhizoma Gastrodiae, Ramulus Uncariae Cum Uncis 15 parts, 5 parts, Radix Glycyrrhizae.
2. be used for the treatment of the pharmaceutical preparation of vertigo as claimed in claim 1, it is characterized in that, dosage form is pharmaceutically acceptable granule, tablet, capsule.
3. be used for the treatment of the pharmaceutical preparation of vertigo as claimed in claim 1, it is characterized in that, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
4. be used for the treatment of the application of pharmaceutical preparation in treatment vertigo medicine of vertigo according to claim 1.
CN201510848213.4A 2015-11-30 2015-11-30 Pharmaceutical preparation for treating vertigo Withdrawn CN105267711A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510848213.4A CN105267711A (en) 2015-11-30 2015-11-30 Pharmaceutical preparation for treating vertigo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510848213.4A CN105267711A (en) 2015-11-30 2015-11-30 Pharmaceutical preparation for treating vertigo

Publications (1)

Publication Number Publication Date
CN105267711A true CN105267711A (en) 2016-01-27

Family

ID=55138101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510848213.4A Withdrawn CN105267711A (en) 2015-11-30 2015-11-30 Pharmaceutical preparation for treating vertigo

Country Status (1)

Country Link
CN (1) CN105267711A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106349283A (en) * 2016-08-23 2017-01-25 陕西源邦生物技术有限公司 Preparation method of high-purity phosphatidylserine
CN106421442A (en) * 2016-11-02 2017-02-22 杨均初 Traditional Chinese medicine composition for treating vertigo and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1105876A (en) * 1994-01-31 1995-08-02 贺易庭 "Dingxuan" medicine for radically treating dizziness disease
CN103446454A (en) * 2012-05-30 2013-12-18 孔祥军 Traditional Chinese medicine for treating dizziness
CN103690866A (en) * 2012-09-28 2014-04-02 青岛信立德中药技术研究开发有限公司 A traditional Chinese medicine composition used for treating vertigo
CN104623325A (en) * 2013-11-12 2015-05-20 青岛食之礼中草药研究所 Traditional Chinese medicine for treating true vertigo
CN104906366A (en) * 2015-06-22 2015-09-16 王菊明 Pharmaceutical preparation for treating delayed menorrhea

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1105876A (en) * 1994-01-31 1995-08-02 贺易庭 "Dingxuan" medicine for radically treating dizziness disease
CN103446454A (en) * 2012-05-30 2013-12-18 孔祥军 Traditional Chinese medicine for treating dizziness
CN103690866A (en) * 2012-09-28 2014-04-02 青岛信立德中药技术研究开发有限公司 A traditional Chinese medicine composition used for treating vertigo
CN104623325A (en) * 2013-11-12 2015-05-20 青岛食之礼中草药研究所 Traditional Chinese medicine for treating true vertigo
CN104906366A (en) * 2015-06-22 2015-09-16 王菊明 Pharmaceutical preparation for treating delayed menorrhea

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
姜晓波: "清眩汤治疗美尼尔氏病", 《山西中医》 *
王立忠: "眩晕病的辨证思路与方法", 《河南中医》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106349283A (en) * 2016-08-23 2017-01-25 陕西源邦生物技术有限公司 Preparation method of high-purity phosphatidylserine
CN106421442A (en) * 2016-11-02 2017-02-22 杨均初 Traditional Chinese medicine composition for treating vertigo and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102671178B (en) Preparation method of Chinese medicinal composition for treating nephrotic syndrome and uremia and application thereof
CN102847061B (en) Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof
CN105267711A (en) Pharmaceutical preparation for treating vertigo
CN107890528B (en) Traditional Chinese medicine composition for treating hyperuricemia and preparation method thereof
CN105434738A (en) Traditional Chinese medicine composition for treating ADHD (Attention Deficit Hyperactivity Disorder) and preparation method thereof
CN1234401C (en) Bi-ant contained dampness dispelling and collaterals dredging medicinal capsule
CN112138126A (en) Composition for effectively relieving dysmenorrhea and preparation method thereof
CN105343660A (en) Traditional Chinese medicinal preparation for treating peripheral vertigo and preparation method of traditional Chinese medicinal preparation
CN105055924A (en) Medicine preparation used for treating migraine
CN104887950A (en) Mastitis treatment traditional Chinese medicine compound
CN104784418A (en) Medicine for curing protrusion of lumbar intervertebral disc
CN104524461A (en) Medicine composition for treating myocarditis and application thereof
CN108904656A (en) The pharmaceutical composition and its preparation method and application for treating cervical spondylosis or lumbar vertebra disease
CN104888080A (en) Traditional Chinese medicine composition for treating insomnia
CN105687765A (en) Lacidipine containing pharmaceutical composition for treating hypertension and preparation method thereof
CN105287829A (en) Chinese herb composition for treating nephritic syndrome and preparation method
CN105106764A (en) Medicinal preparation for treating vomitus gravidarum
CN104873879A (en) Medicinal preparation for treating insomnia
CN104524149A (en) Pharmaceutical composition for preventing and treating acute nephritis and application thereof
CN104689205A (en) Traditional Chinese preparation for treating insomnia and dreamful sleep and preparation method thereof
CN104173808B (en) A kind of Chinese medicine and preparation method thereof for treating flaming-up of the liverfire type hypertension
CN104547695B (en) It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia
CN112755137A (en) Traditional Chinese medicine composition for treating mild and moderate knee osteoarthritis and application thereof
CN111743977A (en) A Chinese medicinal composition for preventing and treating pneumonia and its preparation method
KR20130014767A (en) Oriental medicine composition for chidren's night crying disease and manufacturing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20160127